The fertility industry in China is using artificial intelligence technology to solve the problem of declining birth rates in ...

On December 13th, Maryam Nawaz Sharif, Chief Minister of Punjab Province, Pakistan, led a delegation from the Punjab provincial government to visit BGI Genomics and signed the Memorandum of ...

China’s BGI Genomics has marked its 26th anniversary with the launch of a newly developed AI-powered health management platform for the strategic commitment to global healthcare transformation. The ...

SHANGHAI, Jan 14 (Reuters) - BGI Genomics and Roche Diagnostics have rolled out tests for Alzheimer's disease in China, the companies said, in an effort to expand access to easier-to-use diagnosis ...

Intrahepatic cholangiocarcinoma (iCCA), the second most common primary liver cancer after hepatocellular carcinoma, remains one of the most challenging malignancies to treat due to its highly ...

A new study led by scientists from BGI Genomics' Institute of Intelligent Medical Research (IIMR) has identified early biomarkers and disease neurons associated with Alzheimer's Disease (AD) pathology ...

A recent study has developed a highly accurate risk prediction framework for preterm birth (PTB) that could broaden the potential of AI-driven multi-omics applications in precision obstetrics and ...

SYDNEY (Reuters) - The Chinese government has made an investment in BGI Genomics Co, a listed Chinese company that has supplied millions of COVID-19 tests globally as the gene firm seeks to fund ...

BEIJING (Reuters) - China's BGI Genomics said on Wednesday its coronavirus testing kit has "relatively high accuracy", a day after Sweden said about 3,700 people received false positive results due to ...